0001209191-21-029123.txt : 20210429
0001209191-21-029123.hdr.sgml : 20210429
20210429201117
ACCESSION NUMBER: 0001209191-21-029123
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210428
FILED AS OF DATE: 20210429
DATE AS OF CHANGE: 20210429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lucas Svetlana
CENTRAL INDEX KEY: 0001781292
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 21873133
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-28
0
0001339970
aTYR PHARMA INC
LIFE
0001781292
Lucas Svetlana
3545 JOHN HOPKINS COURT
SUITE 250
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (right to buy)
4.21
2021-04-28
4
A
0
1428
0.00
A
2031-04-28
Common Stock
1428
1428
D
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Nancy Denyes, as Attorney-in-Fact
2021-04-29